Malaysian Genomics Resource Centre Berhad operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Malaysian Genomics Resource Centre Berhad with three other
pharmaceutical manufacturers in Asia:
Pine Capital Group Ltd
sales of 3.60 million Singapore Dollars [US$2.75 million]
Source Natural Foods and Herbal Supplements Ltd
(159.40 million Indian Rupees [US$2.43 million]
FutureChem Co Ltd
based in South Korea
(3.00 billion Korean Won [US$2.82 million]
Malaysian Genomics Resource Centre Berhad reported sales of 9.87 million Malaysian Ringgits (US$2.54 million)
June of 2017.
decrease of 5.4%
versus 2016, when the company's sales were 10.43 million Malaysian Ringgits.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Malaysian Genomics Resource Centre Berhad had sales
of 9.84 million Malaysian Ringgits.